(WASHINGTON)Shares of Targanta Therapeutics Corp. plunged Thursday, a day after a panel of government experts voted against the benefits of the company's antibiotic.READ MORE
(COLLEGE PARK, Md.)Federal health advisers on Wednesday backed the benefits of an experimental antibiotic but rebuffed another, questioning whether it would be able to fight dangerous staph infection...READ MORE
(COLLEGE PARK, Md.)Federal health advisers on Wednesday said an antibiotic developed by Theravance appears safe and effective for fighting "superbug" bacteria, despite potential risks for pregnant wo...READ MORE
(WASHINGTON)Federal health advisers on Wednesday will debate the merits of two experimental antibiotics designed to fight "superbug" bacteria that have grown immune to older drugs.READ MORE
(WASHINGTON)Shares of drugmaker Theravance surged Monday on the release of a federal review of the company's experimental antibiotic, despite concerns about the product's risks to pregnant wom...READ MORE
In early trading Monday, United Therapeutics Corp. (Nasdaq:UTHR) shares fell more than 30 percent on Monday after it said one of its treatments in the FREEDOM-C RIAL did not meet i...READ MORE
(WASHINGTON)Government experts narrowly backed a Johnson & Johnson antibiotic as a treatment against pneumonia Wednesday, despite serious concerns about how the company studied the drug.READ MORE